|
1
|
Tavani A and La Vecchia C: Epidemiology of
renal-cell carcinoma. J Nephrol. 10:93–106. 1997.PubMed/NCBI
|
|
2
|
National Cancer Institute: Surveillance,
epidemiology and end results program. SEER stat fact sheets: Kidney
and renal pelvis cancer. http://seer.cancer.gov/statfacts/html/kidrp.html.
Accessed March 30, 2014.
|
|
3
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 20142014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhejiang Channel XNA: World Kidney Day:
Kidney Cancer incidence increased year by year become 'invisible
killer'. Available at: http://www.zj.xinhuanet.com/news-center/science/2014-03/13/c_119759340.htm.
Accessed 13 March 2014.
|
|
5
|
Chen W, Zheng R, Zhang S, Zhao P, Zeng H,
Zou X and He J: Annual report on status of cancer in China, 2010.
Chin J Cancer Res. 26:48–58. 2014.PubMed/NCBI
|
|
6
|
Motzer RJ, Bander NH and Nanus DM:
Renal-cell carcinoma. N Engl J Med. 335:865–875. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cohen HT and McGovern FJ: Renal-cell
carcinoma. N Engl J Med. 353:2477–2490. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ridge CA, Pua BB and Madoff DC:
Epidemiology and staging of renal cell carcinoma. Semin Intervent
Radiol. 31:3–8. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Huntzinger E and Izaurralde E: Gene
silencing by microRNAs: Contributions of translational repression
and mRNA decay. Nat Rev Genet. 12:99–110. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Perez-Rivas LG, Jerez JM, Carmona R, de
Luque V, Vicioso L, Claros MG, Viguera E, Pajares B, Sánchez A,
Ribelles N, et al: A microRNA signature associated with early
recurrence in breast cancer. PLoS One. 9:e918842014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li JY, Zhang Y, Zhang WH, Jia S, Kang Y
and Zhu XY: Differential distribution of miR-20a and miR-20b may
underly metastatic heterogeneity of breast cancers. Asian Pac J
Cancer Prev. 13:1901–1906. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li D, Ilnytskyy Y, Kovalchuk A, Khachigian
LM, Bronson RT, Wang B and Kovalchuk O: Crucial role for early
growth response-1 in the transcriptional regulation of miR-20b in
breast cancer. Oncotarget. 4:1373–1387. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Guo J, Miao Y, Xiao B, Huan R, Jiang Z,
Meng D and Wang Y: Differential expression of microRNA species in
human gastric cancer versus non-tumorous tissues. J Gastroenterol
Hepatol. 24:652–657. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cheung TH, Man KN, Yu MY, Yim SF, Siu NS,
Lo KW, Doran G, Wong RR, Wang VW, Smith DI, et al: Dysregulated
microRNAs in the pathogenesis and progression of cervical neoplasm.
Cell Cycle. 11:2876–2884. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Coskun E, Neumann M, Schlee C, Liebertz F,
Heesch S, Goekbuget N, Hoelzer D and Baldus CD: MicroRNA profiling
reveals aberrant microRNA expression in adult ETP-ALL and
functional studies implicate a role for miR-222 in acute leukemia.
Leuk Res. 37:647–656. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hui AB, Lin A, Xu W, Waldron L,
Perez-Ordonez B, Weinreb I, Shi W, Bruce J, Huang SH, O'Sullivan B,
et al: Potentially prognostic miRNAs in HPV-associated
oropharyngeal carcinoma. Clin Cancer Res. 19:2154–2162. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yamaguchi T, Iijima T, Wakaume R,
Takahashi K, Matsumoto H, Nakano D, Nakayama Y, Mori T, Horiguchi S
and Miyaki M: Underexpression of miR-126 and miR-20b in hereditary
and nonhereditary colorectal tumors. Oncology. 87:58–66. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Müller S and Nowak K: Exploring the
miRNA-mRNA regulatory network in clear cell renal cell carcinomas
by next-generation sequencing expression profiles. Biomed Res Int.
2014:9484082014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Edge SB, Byrd DR, Compton CC, Fritz AG,
Greene FL and Trotti A: AJCC Cancer Staging Manual. 7th edition.
Springer Verlag; New York, NY: pp. 479–489. 2010
|
|
21
|
Cascio S, D'Andrea A, Ferla R, Surmacz E,
Gulotta E, Amodeo V, Bazan V, Gebbia N and Russo A: miR-20b
modulates VEGF expression by targeting HIF-1 alpha and STAT3 in
MCF-7 breast cancer cells. J Cell Physiol. 224:242–249.
2010.PubMed/NCBI
|
|
22
|
Saleiban A, Faxälv L, Claesson K, Jönsson
JI and Osman A: miR-20b regulates expression of
proteinase-activated receptor-1 (PAR-1) thrombin receptor in
melanoma cells. Pigment Cell Melanoma Res. 27:431–441. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Visone R and Croce CM: MiRNAs and cancer.
Am J Pathol. 174:1131–1138. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Voinnet O: Origin, biogenesis and activity
of plant microRNAs. Cell. 136:669–687. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Junker K, Ficarra V, Kwon ED, Leibovich
BC, Thompson RH and Oosterwijk E: Potential role of genetic markers
in the management of kidney cancer. Eur Urol. 63:333–340. 2013.
View Article : Google Scholar
|
|
26
|
Katada T, Ishiguro H, Kuwabara Y, Kimura
M, Mitui A, Mori Y, Ogawa R, Harata K and Fujii Y: microRNA
expression profile in undifferentiated gastric cancer. Int J Oncol.
34:537–542. 2009.PubMed/NCBI
|
|
27
|
Wu S, Huang S, Ding J, Zhao Y, Liang L,
Liu T, Zhan R and He X: Multiple microRNAs modulate p21Cip1/Waf1
expression by directly targeting its 3′ untranslated region.
Oncogene. 29:2302–2308. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang X, Tang S, Le SY, Lu R, Rader JS,
Meyers C and Zheng ZM: Aberrant expression of oncogenic and
tumor-suppressive microRNAs in cervical cancer is required for
cancer cell growth. PLoS One. 3:e25572008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
George DJ and Kaelin WG Jr: The von
Hippel-Lindau protein, vascular endothelial growth factor and
kidney cancer. N Engl J Med. 349:419–421. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Motzer RJ and Basch E: Targeted drugs for
metastatic renal cell carcinoma. Lancet. 370:2071–2073. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
de Martino M, Haitel A, Schatzl G and
Klatte T: The protease activated receptor 1 gene variation IVSn-14
A>T is associated with distant metastasis and cancer specific
survival in renal cell carcinoma. J Urol. 190:1392–1397. 2013.
View Article : Google Scholar : PubMed/NCBI
|
